Edoxaban vs Ipilimumab

Edoxaban vs Ipilimumab: Overview

This comparison examines the pharmacological differences between Edoxaban and Ipilimumab.

Mechanism of Action

Edoxaban: Direct, selective inhibitor of Factor Xa preventing thrombin generation and clot formation.

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Edoxaban — 10-14 hours; Ipilimumab — 14.7 days.

Chemical Properties

Molecular Formula: Edoxaban — C24H30ClN7O4S.

Molecular Weight: Edoxaban — 548.0530 g/mol.

Type: Edoxaban — Small molecule; Ipilimumab — Antibody.